Zawadzki · Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2025 · randomized controlled trial · n=138

App-based mindfulness meditation reduces stress in novice meditators: a randomized controlled trial of headspace using ecological momentary assessment.

Level 2 - randomized trial

Randomized controlled trial comparing an intervention group to a wait-list control group.

PubMed 40257119 · doi:10.1093/abm/kaaf025 · record verified 2026-08-26

What was done

A randomized controlled trial evaluated the Headspace app versus an inactive wait-list control over an 8-week period in non-faculty university employees (n = 138; mean age 38.19 years; 75.36% female; 54.5% White, 27.54% Hispanic). Participants in the intervention arm were instructed to complete 10 minutes of app-guided meditation daily. Stress dimensions (subjective stress, stressor appraisals, perceived coping, and perseverative cognitions) were captured via ecological momentary assessments delivered five times daily across four consecutive days at baseline, week 2, week 5, and week 8 (6,260 total observations), analyzed using hierarchical linear models.

What was found

The abstract reports significant condition-by-time interactions for subjective stress, perceived coping, and perseverative cognitions, but does not report numerical effect sizes, test statistics, confidence intervals, or exact p-values. Participants in the meditation group reported reductions in subjective stress and perseverative cognitions by week 2 and increases in perceived coping by week 5 relative to baseline, with benefits sustained through week 8. No changes occurred in stressor appraisals. Control participants reported increases in subjective stress and perseverative cognitions, alongside decreases in coping, throughout the study.

Why it matters

This study shows that brief, app-based mindfulness practice can yield rapid and sustained stress-reduction benefits in naturalistic daily environments among working adults.

Limits

The abstract provides no numerical effect estimates or confidence intervals. The trial used an inactive wait-list control rather than an active digital comparator, which does not account for placebo or expectancy effects. The sample was predominantly female (75.36%) and recruited from a single university site, and outcomes relied exclusively on self-reported momentary assessments without physiological stress measures.